In clinical studies, two heterozygous variants [p.Gln 329* and c.1565-2A>G (splice donor before exon 11)] in ANKRD31 were found in patients with premature ovarian insufficiency (POI) (38). Here, ANKRD31 is linked to Premature ovarian insufficiency.